Le Lézard

REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight

MindWalk Holdings Corp. ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today ...
BioSpace

6 FDA Decisions To Watch in Q1 2026

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...